2 completed, 1 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Recruiting 1 |
Follow Prostate Adenocarcinoma: new trials by email Literature Review of Prostate Adenocarcinoma trials Research Report on Prostate Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy Piflufolastat, PSMA PET/CT Scan, PSMA PET/MRI scan - Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer | Phase 4 | Recruiting | OHSU Knight Cancer Institute | 80 | 2024-06-25 | 2026-10-20 |
| Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain Self-Administered Nitrous Oxide, Oxygen - Prostate Disease, Malignancy | Phase 4 | Completed | Beth Israel Deaconess Medical Center | 143 | 2021-12-12 | 2024-01-30 |
| A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy Fesoterodine, Placebo oral tablet - Prostate Adenocarcinoma | Phase 4 | Completed | Abramson Cancer Center at Penn Medicine | 3 | 2012-01-01 | 2020-04-28 |
Anxiety Disorders (1) · Neoplasms (1) · Pain (1) · Prostatic Diseases (1) · Prostatic Hyperplasia (1) · Prostatic Neoplasms (1)
Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Male Urogenital Diseases (1) · Mental Disorders (1) · Neoplasms by Site (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid (1) · Magnetic Resonance Spectroscopy (1) · Nitrous Oxide (1) · Oxygen (1) · Specimen Handling (1) · fesoterodine (1)
Abramson Cancer Center at Penn Medicine (1) · Beth Israel Deaconess Medical Center (1) · OHSU Knight Cancer Institute (1)
United States (3)
David Lee, MD (1) · Heidi Rayala, MD, PhD (1) · Nadine Mallak, MD (1)